Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 26 | 2023 | 935 | 5.090 |
Why?
|
| Transcription Factors | 18 | 2019 | 681 | 3.940 |
Why?
|
| Cathepsin L | 7 | 2019 | 15 | 2.830 |
Why?
|
| Vitis | 4 | 2019 | 31 | 2.160 |
Why?
|
| Homeodomain Proteins | 5 | 2019 | 132 | 1.880 |
Why?
|
| Plant Extracts | 5 | 2019 | 286 | 1.870 |
Why?
|
| Cell Line, Tumor | 28 | 2020 | 2231 | 1.680 |
Why?
|
| Repressor Proteins | 3 | 2019 | 249 | 1.540 |
Why?
|
| Cell Nucleus | 4 | 2020 | 366 | 1.480 |
Why?
|
| Cell Movement | 16 | 2020 | 571 | 1.350 |
Why?
|
| Bone Neoplasms | 4 | 2019 | 45 | 1.250 |
Why?
|
| Breast Neoplasms | 10 | 2023 | 1502 | 1.240 |
Why?
|
| Neoplasm Metastasis | 6 | 2023 | 219 | 1.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2019 | 807 | 1.170 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 307 | 1.010 |
Why?
|
| Serpins | 4 | 2012 | 27 | 0.920 |
Why?
|
| Thiazoles | 2 | 2014 | 74 | 0.880 |
Why?
|
| Cell Adhesion | 5 | 2020 | 212 | 0.860 |
Why?
|
| Reactive Oxygen Species | 4 | 2013 | 461 | 0.840 |
Why?
|
| Indoles | 2 | 2014 | 158 | 0.820 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 110 | 0.810 |
Why?
|
| Oxidative Stress | 6 | 2020 | 938 | 0.800 |
Why?
|
| Subcellular Fractions | 3 | 2017 | 77 | 0.790 |
Why?
|
| Male | 29 | 2023 | 20025 | 0.770 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 90 | 0.760 |
Why?
|
| Protease Inhibitors | 2 | 2017 | 49 | 0.720 |
Why?
|
| Humans | 41 | 2023 | 37093 | 0.700 |
Why?
|
| Epithelial Cells | 7 | 2012 | 384 | 0.690 |
Why?
|
| CCAAT-Binding Factor | 1 | 2019 | 2 | 0.690 |
Why?
|
| Cell Proliferation | 9 | 2020 | 1198 | 0.680 |
Why?
|
| Peroxidase | 1 | 2019 | 49 | 0.670 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 67 | 0.660 |
Why?
|
| HMGA2 Protein | 1 | 2018 | 1 | 0.660 |
Why?
|
| Signal Transduction | 11 | 2019 | 1908 | 0.650 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2015 | 269 | 0.640 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 111 | 0.640 |
Why?
|
| Mesoderm | 5 | 2017 | 70 | 0.630 |
Why?
|
| Neoplasm Invasiveness | 8 | 2017 | 251 | 0.620 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2014 | 99 | 0.610 |
Why?
|
| beta Karyopherins | 1 | 2017 | 4 | 0.610 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 17 | 0.600 |
Why?
|
| Dipeptides | 1 | 2017 | 32 | 0.580 |
Why?
|
| Prostate | 3 | 2018 | 154 | 0.580 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 169 | 0.570 |
Why?
|
| Apoptosis | 9 | 2020 | 1398 | 0.550 |
Why?
|
| Cadherins | 5 | 2018 | 90 | 0.540 |
Why?
|
| Autophagy | 1 | 2016 | 116 | 0.520 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 65 | 0.500 |
Why?
|
| Mice, Nude | 5 | 2019 | 337 | 0.500 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 409 | 0.490 |
Why?
|
| Cathepsin D | 1 | 2014 | 17 | 0.480 |
Why?
|
| Cell Survival | 5 | 2020 | 864 | 0.480 |
Why?
|
| RANK Ligand | 3 | 2015 | 13 | 0.470 |
Why?
|
| Superoxides | 1 | 2014 | 53 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2011 | 136 | 0.440 |
Why?
|
| Arabidopsis | 1 | 2014 | 95 | 0.430 |
Why?
|
| Sesquiterpenes | 1 | 2012 | 32 | 0.430 |
Why?
|
| Integrins | 1 | 2011 | 51 | 0.390 |
Why?
|
| Transfection | 6 | 2012 | 523 | 0.390 |
Why?
|
| Chromogranin A | 1 | 2010 | 7 | 0.370 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 194 | 0.370 |
Why?
|
| Mice | 7 | 2020 | 5913 | 0.370 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 33 | 0.370 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 515 | 0.370 |
Why?
|
| Proteins | 2 | 2003 | 369 | 0.350 |
Why?
|
| Cell Differentiation | 2 | 2010 | 587 | 0.350 |
Why?
|
| Breast | 2 | 2018 | 135 | 0.340 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 578 | 0.340 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1015 | 0.320 |
Why?
|
| Disease Progression | 6 | 2018 | 601 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2008 | 172 | 0.310 |
Why?
|
| Carcinoma | 1 | 2008 | 96 | 0.300 |
Why?
|
| Phosphorylation | 5 | 2019 | 928 | 0.300 |
Why?
|
| Feedback, Physiological | 2 | 2017 | 31 | 0.280 |
Why?
|
| Animals | 10 | 2020 | 15081 | 0.280 |
Why?
|
| RNA Interference | 3 | 2019 | 243 | 0.280 |
Why?
|
| Gene Silencing | 2 | 2020 | 151 | 0.280 |
Why?
|
| Pyridines | 2 | 2019 | 116 | 0.280 |
Why?
|
| Proteomics | 2 | 2019 | 325 | 0.260 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2016 | 77 | 0.260 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 35 | 0.250 |
Why?
|
| Cell Communication | 2 | 2020 | 97 | 0.240 |
Why?
|
| Caspase 3 | 2 | 2016 | 207 | 0.240 |
Why?
|
| Vimentin | 2 | 2018 | 37 | 0.230 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2014 | 78 | 0.220 |
Why?
|
| Receptors, Androgen | 4 | 2014 | 126 | 0.210 |
Why?
|
| Time Factors | 5 | 2014 | 1742 | 0.210 |
Why?
|
| Osteoclasts | 2 | 2015 | 14 | 0.210 |
Why?
|
| Extracellular Matrix | 3 | 2012 | 115 | 0.210 |
Why?
|
| Tyrosine | 1 | 2002 | 118 | 0.210 |
Why?
|
| Capacity Building | 1 | 2022 | 87 | 0.200 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 803 | 0.200 |
Why?
|
| Protein Transport | 3 | 2020 | 302 | 0.190 |
Why?
|
| Community-Institutional Relations | 1 | 2022 | 187 | 0.190 |
Why?
|
| Female | 8 | 2023 | 20969 | 0.180 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 109 | 0.170 |
Why?
|
| Egtazic Acid | 1 | 2019 | 13 | 0.170 |
Why?
|
| Tyrphostins | 1 | 2019 | 15 | 0.170 |
Why?
|
| Durapatite | 1 | 2019 | 17 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 173 | 0.160 |
Why?
|
| Metabolomics | 1 | 2019 | 81 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2019 | 86 | 0.160 |
Why?
|
| Up-Regulation | 3 | 2016 | 513 | 0.160 |
Why?
|
| Down-Regulation | 3 | 2016 | 435 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 623 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 494 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 252 | 0.150 |
Why?
|
| Neoplasms | 2 | 2019 | 1103 | 0.150 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 59 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 661 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2010 | 103 | 0.150 |
Why?
|
| Caspase 12 | 1 | 2016 | 4 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 98 | 0.140 |
Why?
|
| Tissue Distribution | 1 | 2017 | 207 | 0.140 |
Why?
|
| Chloroquine | 1 | 2016 | 19 | 0.140 |
Why?
|
| Cathepsins | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cell Line | 1 | 2020 | 1354 | 0.140 |
Why?
|
| Cystatin C | 1 | 2016 | 24 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2010 | 859 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2023 | 642 | 0.140 |
Why?
|
| Leucine | 1 | 2016 | 29 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2017 | 121 | 0.140 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 55 | 0.140 |
Why?
|
| Environmental Exposure | 2 | 2015 | 216 | 0.140 |
Why?
|
| Calcium | 1 | 2019 | 480 | 0.140 |
Why?
|
| Organ Specificity | 2 | 2014 | 129 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 152 | 0.130 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 10 | 0.130 |
Why?
|
| Hazardous Substances | 1 | 2015 | 18 | 0.130 |
Why?
|
| Chemoprevention | 1 | 2015 | 35 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2015 | 35 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 182 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2019 | 400 | 0.130 |
Why?
|
| Models, Biological | 2 | 2017 | 677 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 626 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2005 | 63 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2013 | 54 | 0.120 |
Why?
|
| Gene Expression | 3 | 2012 | 674 | 0.120 |
Why?
|
| Cytokines | 1 | 2018 | 602 | 0.120 |
Why?
|
| Imidazoles | 1 | 2014 | 126 | 0.120 |
Why?
|
| Protein Binding | 1 | 2017 | 972 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 114 | 0.120 |
Why?
|
| Lysosomes | 1 | 2014 | 91 | 0.110 |
Why?
|
| Neurons | 1 | 2020 | 1175 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1039 | 0.110 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 18 | 0.110 |
Why?
|
| Caspase 7 | 1 | 2012 | 16 | 0.110 |
Why?
|
| Rats | 1 | 2020 | 3483 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2014 | 444 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2020 | 339 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2379 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 213 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 172 | 0.100 |
Why?
|
| Integrin alpha2 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 122 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 69 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 189 | 0.090 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 17 | 0.090 |
Why?
|
| Androgens | 1 | 2010 | 89 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2011 | 399 | 0.090 |
Why?
|
| Antioxidants | 1 | 2012 | 416 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2009 | 12 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 10 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2008 | 502 | 0.080 |
Why?
|
| Bone Remodeling | 1 | 2008 | 9 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2008 | 5 | 0.080 |
Why?
|
| Middle Aged | 2 | 2023 | 10129 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 68 | 0.080 |
Why?
|
| Mice, SCID | 1 | 2008 | 150 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 70 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 93 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2006 | 17 | 0.070 |
Why?
|
| Aged | 1 | 2018 | 6741 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2008 | 191 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2006 | 49 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1518 | 0.070 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2005 | 3 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 144 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 251 | 0.060 |
Why?
|
| Kenya | 1 | 2023 | 50 | 0.060 |
Why?
|
| p21-Activated Kinases | 1 | 2003 | 16 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 22 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2003 | 46 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 86 | 0.050 |
Why?
|
| Phenotype | 2 | 2020 | 689 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2023 | 117 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 11712 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 52 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 408 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 433 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2020 | 45 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 276 | 0.050 |
Why?
|
| Africa | 1 | 2019 | 76 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2019 | 69 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2022 | 322 | 0.040 |
Why?
|
| Teaching | 1 | 2019 | 55 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 442 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2022 | 317 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2020 | 326 | 0.040 |
Why?
|
| Registries | 1 | 2019 | 335 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 893 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 143 | 0.030 |
Why?
|
| Child | 1 | 2023 | 3131 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2014 | 18 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 122 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 84 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 190 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 67 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 76 | 0.020 |
Why?
|
| United States | 1 | 2019 | 4223 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 176 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 81 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 63 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 156 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 136 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 133 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 246 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 213 | 0.020 |
Why?
|
| Clone Cells | 1 | 2006 | 47 | 0.020 |
Why?
|
| Environment | 1 | 2006 | 138 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2005 | 10 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 58 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1207 | 0.010 |
Why?
|